Sign In
Buy AGL
$91.61
-5.14 (-5.31%)
At Close: Jul 31, 2026
Agilon Health cuts 2023 revenue, medical margin outlook but provides upbeat 2024 view
06:12am, Friday, 05'th Jan 2024
Shares of Agilon Health Inc. AGL, -0.25% were indicated down more than 1% in Friday's premarket, after the health care services company lowered its 2023 margin outlook, citing higher costs, but provid
agilon health: High Growth But Unsustainable Economics
09:18am, Monday, 20'th Nov 2023
agilon health's full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in
agilon health, inc. (AGL) Q3 2023 Earnings Call Transcript
07:51pm, Sunday, 05'th Nov 2023
Start Time: 16:30 January 1, 0000 5:29 PM ET agilon health, inc. (NYSE:AGL ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Mat
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics
06:47pm, Thursday, 02'nd Nov 2023
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Stree
agilon health Sets Date to Report Third Quarter 2023 Financial Results
04:30pm, Wednesday, 11'th Oct 2023
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial res
agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation
11:31pm, Wednesday, 13'th Sep 2023
agilon health expects positive adjusted EBITDA in 2023 and is experiencing double-digit net sales growth. The company's growth is driven by an increase in the number of members and partnerships with l
agilon health, inc. (AGL) Q2 2023 Earnings Call Transcript
04:27pm, Friday, 04'th Aug 2023
agilon health, inc. (NYSE:AGL ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Matthew Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Office
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
12:01am, Friday, 04'th Aug 2023
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to W
Agilon Health (AGL) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Thursday, 03'rd Aug 2023
Agilon Health (AGL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.04 per share a year ago.
agilon health: A Hold Until Margins Are Improved
02:19am, Friday, 30'th Jun 2023
agilon health has achieved its first quarter with over $1 billion in revenues, largely due to significant membership growth. AGL is taking strong steps to divert capital to buy back shares. The improv
Top Growth Stocks for June 2023
12:50pm, Tuesday, 06'th Jun 2023
These are the growth stocks with the fastest EPS and revenue growth heading into June.
agilon health, inc. (AGL) Q1 2023 Earnings Call Transcript
07:43pm, Saturday, 13'th May 2023
agilon health, inc. (NYSE:AGL ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lis
Agilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates
07:06pm, Tuesday, 09'th May 2023
Agilon Health (AGL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.
agilon health to Participate in Upcoming Investor Conferences
04:15pm, Wednesday, 03'rd May 2023
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the follow
4 Healthcare Stocks Poised to Beat Q1 Earnings Estimates
12:11pm, Tuesday, 25'th Apr 2023
Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (A
